Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Early diagnosis and a multidisciplinary approach are crucial for children with Trichothiodystrophy and hidden learning disorders.

Caloric restriction improves skin and fur structure but can cause muscle loss and movement issues.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Baricitinib is effective for severe alopecia areata but has some side effects.

A teenager's hair with alternating white and dark bands, known as Pili annulati, is a genetic condition that is usually harmless and often considered attractive.

Acne can be treated but may cause emotional distress and mental health issues.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Alopecia can negatively affect a person's mental health.

Astressin-B can reverse and prevent hair loss in stressed mice.

People with hair loss often experience lower quality of life, depression, and self-esteem issues.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

A child with a rare vitamin D-resistant condition improved with treatment.

Tissue expansion can help restore hair.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Finasteride can cause skin rash.

Both fixed and incremental laser treatments effectively reduced underarm hair, but the fixed method was less painful.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.